Relmada Therapeutics, Inc. (RLMD)

Relmada Therapeutics Market Cap

Relmada Therapeutics has a market cap or net worth of $90.30 million as of September 29, 2023. Its market cap has decreased by -89.95% in one year.

• Market Cap: 90.30M
• Enterprise Value: -23.72M
• 1-Year Change: -89.95%
• Ranking: #4331
• Category: Micro-Cap
• Stock Price: $3.00

Market Cap Chart

Since September 30, 2015, Relmada Therapeutics's market cap has increased from $56.60M to $90.30M, an increase of 59.54%. That is a compound annual growth rate of 6.01%.

Market Cap History

Date	Market Cap	% Change
Sep 28, 2023	88.50M	-6.65%
Sep 27, 2023	94.80M	-
Sep 26, 2023	94.80M	1.61%
Sep 25, 2023	93.30M	11.07%
Sep 22, 2023	84.00M	-2.78%
Sep 21, 2023	86.40M	-3.03%
Sep 20, 2023	89.10M	6.07%
Sep 19, 2023	84.00M	-5.72%
Sep 18, 2023	89.10M	-4.19%
Sep 15, 2023	93.00M	-6.63%
Sep 14, 2023	99.60M	-0.60%
Sep 13, 2023	100.20M	-1.67%
Sep 12, 2023	101.90M	-0.97%
Sep 11, 2023	102.90M	-3.74%
Sep 8, 2023	106.90M	-
Sep 7, 2023	106.90M	-3.26%
Sep 6, 2023	110.50M	-2.90%
Sep 5, 2023	113.80M	-0.26%
Sep 1, 2023	114.10M	12.19%
Aug 31, 2023	101.70M	-
Aug 30, 2023	101.70M	1.19%
Aug 29, 2023	100.50M	-3.74%
Aug 28, 2023	104.40M	6.42%
Aug 25, 2023	98.10M	2.19%
Aug 24, 2023	96.00M	8.84%

View and export this data all the way back to 2015. Start Free Trial.

Related Stocks

Company	Market Cap
DiaMedica Therapeutics	99.43M
PhenomeX	98.50M
Genenta Science	98.23M
Cara Therapeutics	96.80M
Armata Pharmaceuticals	96.46M
Renalytix	94.06M
Burning Rock Biotech	93.96M
Achieve Life Sciences	93.50M